Speaker illustration

Doctor Ramzi Ajjan

Leeds (United Kingdom of Great Britain & Northern Ireland)

RA Ajjan (FRCP, MMed.Sci, PhD) is a Professor of Metabolic Medicine and a Consultant in Diabetes/Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. He was successful at obtaining a Clinician Scientist Award from the NIHR in 2005 and developed a spectrum of basic, translational and clinical research studies. His work collectively aims to reduce cardiovascular complications in diabetes by improving glycaemia and ameliorating the thrombotic environment in this condition. His clinical studies are focused on optimising glycaemic control while his translational work aims to uncover novel therapeutic targets to reduce the hypofibrinolytic environment, a key abnormality in diabetes and which increases the risk of vascular thrombotic events. He has over 150 publications including original articles, reviews and book chapters.

Adverse glycaemic measures in cardiac patients: HbA1c fails to provide the full picture.

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session: Modern Glycaemic Management to reduce CV risk in Diabetes


This platform is supported by

logo Novo Nordisk